BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 18946205)

  • 1. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat intakes of children with PKU on low phenylalanine diets.
    Rose HJ; White F; Macdonald A; Rutherford PJ; Favre E
    J Hum Nutr Diet; 2005 Oct; 18(5):395-400. PubMed ID: 16150136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of natural protein intake in Dutch phenylketonuria patients: insight into estimation or measurement of dietary intake.
    van Rijn M; Jansma J; Brinksma A; Bakker HD; Boers GH; Carbasius-Weber E; Douwes AC; van den Herberg A; Ter Horst NM; de Klerk JB; de Koning TJ; van den Ploeg L; Rubio-Gozalbo ME; Sels JP; Sengers RC; de Valk HW; Termeulen H; Zweers H; van Spronsen FJ
    J Am Diet Assoc; 2008 Oct; 108(10):1704-7. PubMed ID: 18926138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled diet in phenylketonuria may cause serum carnitine deficiency.
    Vilaseca MA; Briones P; Ferrer I; Campistol J; Riverola A; Castillo P; Ramon F
    J Inherit Metab Dis; 1993; 16(1):101-4. PubMed ID: 8487489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising growth in phenylketonuria: current state of the clinical evidence base.
    Dokoupil K; Gokmen-Ozel H; Lammardo AM; Motzfeldt K; Robert M; Rocha JC; van Rijn M; Ahring K; Bélanger-Quintana A; MacDonald A
    Clin Nutr; 2012 Feb; 31(1):16-21. PubMed ID: 21959353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria.
    Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I
    Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body protein in prepubertal children with phenylketonuria.
    Allen JR; Baur LA; Waters DL; Humphries IR; Allen BJ; Roberts DC; Gaskin KJ
    Eur J Clin Nutr; 1996 Mar; 50(3):178-86. PubMed ID: 8654332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil.
    Barretto JR; Silva LR; Leite ME; Boa-Sorte N; Pimentel H; Purificação AC; Carvalho G; Fontes MI; Amorim T
    Nutr Res; 2008 Mar; 28(3):208-11. PubMed ID: 19083409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of essential fatty acid supplementation in phenylketonuria.
    Cleary MA; Feillet F; White FJ; Vidailhet M; Macdonald A; Grimsley A; Maurin N; de Baulny HO; Rutherford PJ
    Eur J Clin Nutr; 2006 Jul; 60(7):915-20. PubMed ID: 16523206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
    Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
    J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched chain amino acids as a parameter for catabolism in treated phenylketonuria.
    Illsinger S; Lücke T; Meyer U; Vaske B; Das AM
    Amino Acids; 2005 Feb; 28(1):45-50. PubMed ID: 15611845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Eur J Clin Nutr; 2011 Feb; 65(2):275-8. PubMed ID: 21119696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein metabolism in adult patients with phenylketonuria.
    van Rijn M; Hoeksma M; Sauer P; Szczerbak B; Gross M; Reijngoud DJ; van Spronsen F
    Nutrition; 2007 Jun; 23(6):445-53. PubMed ID: 17507200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to diet and quality of life in patients with phenylketonuria.
    Cotugno G; Nicolò R; Cappelletti S; Goffredo BM; Dionisi Vici C; Di Ciommo V
    Acta Paediatr; 2011 Aug; 100(8):1144-9. PubMed ID: 21342250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult patients with well-controlled phenylketonuria tolerate incidental additional intake of phenylalanine.
    van Rijn M; Hoeksma M; Sauer PJ; Modderman P; Reijngoud DJ; van Spronsen FJ
    Ann Nutr Metab; 2011; 58(2):94-100. PubMed ID: 21474926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of free L-carnitine levels in type II diabetic women with and without complications.
    Poorabbas A; Fallah F; Bagdadchi J; Mahdavi R; Aliasgarzadeh A; Asadi Y; Koushavar H; Vahed Jabbari M
    Eur J Clin Nutr; 2007 Jul; 61(7):892-5. PubMed ID: 17311064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.